title: Novel biomarkers for overactive bladder.
abstract: Biomarkers constitute any objectively measurable indicator of a biological process. The classic biomarker used in the diagnosis of overactive bladder (OAB) has been detrusor overactivity, which is assessed urodynamically. In the search for a reliable, noninvasive alternative to urodynamics, interest has focused on genetic, imaging, and urinary factors. Along with other cytokines detectable in urine, prostaglandin E2 and nerve growth factor are indicators of low-grade inflammation. Although they correlate with OAB symptom severity, they have not been shown to have independent prognostic benefit. Imaging biomarkers have been investigated since the earliest days of video urodynamics. Despite extensive research on the ultrasonographic estimation of bladder wall thickness, further standardization of the technique is required before conclusions can be reached regarding diagnostic accuracy. Genetic factors contribute approximately half of the total risk for urgency incontinence. Functional polymorphisms of the cytochrome P450 IID6 gene significantly alter the metabolism of some commonly used anticholinergic drugs, but no genetic loci that influence risk of OAB have been definitively identified. The first genome-wide association studies for OAB are in progress, and should identify new susceptibility genes. Although current putative biomarkers correlate with OAB severity, much future work is required to assess their prognostic value, and establish their role in clinical practice.
authors.affiliation: Institute of Reproductive and Developmental Biology, Hammersmith Hospital Campus, London, UK.
authors.forename: Rufus
authors.initials: R
authors.lastname: Cartwright
authors.forename: Iram
authors.initials: I
authors.lastname: Afshan
authors.forename: Alexandros
authors.initials: A
authors.lastname: Derpapas
authors.forename: Gopalan
authors.initials: G
authors.lastname: Vijaya
authors.forename: Vik
authors.initials: V
authors.lastname: Khullar
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism / Q000652:urine; D015232:Dinoprostone / Q000378:metabolism / Q000652:urine; D006801:Humans; D020932:Nerve Growth Factor / Q000378:metabolism / Q000652:urine; D001743:Urinary Bladder / Q000378:metabolism / Q000473:pathology; D053201:Urinary Bladder, Overactive / Q000175:diagnosis* / Q000378:metabolism* / Q000473:pathology; D014549:Urinary Incontinence / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology
chemical_list: D015415:Biomarkers; D020932:Nerve Growth Factor; D015232:Dinoprostone